Pseudomonas aeruginosa displays tremendous metabolic diversity, controlled in part by the abundance of transcription regulators in the genome. We have been investigating P. aeruginosa's response to the host, particularly changes regulated by the hostderived quaternary amines choline and glycine betaine (GB). We previously identified GbdR as an AraC family transcription factor that directly regulates choline acquisition from host phospholipids (via binding to plcH and pchP promoters), is required for catabolism of the choline metabolite GB, and is an activator that induces transcription in response to GB or dimethylglycine. Our goal was to characterize the GbdR regulon in P. aeruginosa by using genetics and chemical biology in combination with transcriptomics and in vitro DNA-binding assays. Here we show that GbdR activation regulates transcription of 26 genes from 12 promoters, 11 of which have measureable binding to GbdR in vitro. The GbdR regulon includes the genes encoding GB, dimethylglycine, sarcosine, glycine, and serine catabolic enzymes and the BetX and CbcXWV quaternary amine transport proteins. We characterized the GbdR consensus binding site and used it to identify that the recently characterized acetylcholine esterase gene, choE (PA4921), is also regulated by GbdR. The regulon member not directly controlled by GbdR is the secreted lipase gene lipA, which was also the only regulon member repressed under GbdR-activating conditions. Determination of the GbdR regulon provides deeper understanding of how GbdR links bacterial metabolism and virulence. Additionally, identification of two uncharacterized regulon members suggests roles for these proteins in response to choline metabolites.
T
he impressive metabolic versatility of Pseudomonas aeruginosa is largely controlled by an abundance of transcriptional regulators, estimated to comprise nearly 9% of the P. aeruginosa genome (1) . This genomic investment in regulators of transcription points to the importance of transcriptional adaptation strategies, whereby the ensemble activities of these regulators control specific suites of transcripts for each set of environmental conditions. While bioinformatics can readily identify candidate transcription factors, it provides much less information about target genes in bacteria and very little about the ligands or environmental conditions controlling these regulators.
We previously identified the transcriptional regulator GbdR in P. aeruginosa as necessary for choline catabolism via glycine betaine (GB) and dimethylglycine (DMG) intermediates (2) , as presented in the catabolic pathway shown in Fig. 1 . GbdR was also necessary for the acquisition of choline via the hemolytic phospholipase C (PlcH) virulence factor and the periplasmic phosphorylcholine phosphatase (PchP) (3) . Evidence from genetics and chemical biology experiments supports the choline catabolites GB and DMG as inducing molecules for GbdR-dependent transcriptional activation (2, 4) . GB is used nearly universally as an osmoprotectant and general stress protectant in bacteria, as well as playing a similar role in most eukaryotes and a number of Archaea (5) . Choline is a canonical component of eukaryotes, most commonly as the head group of phosphatidylcholine and sphingomyelin. Choline contributes to bacterial interactions with eukaryotes (6, 7) and has been hypothesized to have roles in additional settings (8) (9) (10) . We have demonstrated that it is not choline itself, but rather GB, that is important for P. aeruginosa survival in the mammalian lung (11) . GB alters gene transcription via unknown mechanisms from promoters controlled by BetI and GbsR (12) (13) (14) , but the only specific GB-sensing transcription factor currently described in bacteria is GbdR. Therefore, we were interested in the scope of GbdR transcriptional control in P. aeruginosa. We had previously shown direct GbdR regulation of plcH and pchP (3) and presented genetic evidence that GbdR regulated the gbcA and -B genes and the dgc operon (2). Here we were interested in discovering the identities of the core members of the GbdR regulon.
Our objective was to identify the core members of the GbdR regulon that are regulated in a GB/DMG-dependent manner and provide evidence that regulation was direct by using in vitro DNA binding assays. Here, we demonstrate that GbdR controls induction of at least 25 genes from 11 promoters by using a combination of genetics and chemical biology approaches coupled to transcriptome analyses. We have validated previously unverified interactions by GbdR DNA-binding assays and used DNase I footprinting along with sequence alignments to refine the GbdR consensus binding site. The defined consensus allowed us to predict, and then subsequently demonstrate, that GbdR also controls transcription of the recently described acetylcholine esterase, ChoE (15) , encoded by PA4921 (choE).
MATERIALS AND METHODS
Bacterial growth conditions. P. aeruginosa PA14 and derived strains (Table 1) were maintained in LB-Lennox broth or agar plates or on Pseudomonas isolation agar (PIA) with gentamicin added to 50 g/ml when necessary. During genetic manipulations (described below), PIA (BDDifco) was used to select against Escherichia coli, with gentamicin added to 50 g/ml when necessary. MOPS (morpholinepropanesulfonic acid) minimal medium (16) was used during P. aeruginosa growth and transcriptional induction experiments, with gentamicin added at 25 g/ml when necessary; the carbon source and inducer identities with relevant concentrations are detailed below. Details for standard P. aeruginosa growth and maintenance were described previously (17) . The E. coli cells used for molecular and genetic manipulations were maintained on LB medium or LB agar, with gentamicin added to 7 g/ml or 10 g/ml, respectively.
Ethylcholine and diethylcholine syntheses. Ethylcholine (EtCho) (IU-PAC, N-ethyl-2-hydroxy-N,N-dimethylethanaminium bromide; Chemical Abstracts Service [CAS] no. 13205-69-1) was synthesized using the strategy of Jao et al. (13) , as modified in our previous work (4), by combining dimethylethanolamine and bromoethane in tetrahydrofuran (THF), followed by extensive washing with dry THF. The product was validated by electrospray ionization mass spectrometry (ESI-MS) ([M] ϩ ϭ 118.21) and was greater than 95% pure by relative ion abundance (some THF remained). Tandem MS (MS/MS) fragmentation resulted in two major expected fragments: (i) loss of the ethanol group from the amine ([M] ϩ ϭ 74.07) and (ii) loss of the ethane group from the amine ([M] ϩ ϭ 90.13). Diethylcholine (DiCho) (IUPAC, N,N-diethyl-2-hydroxy-N-methylethanaminium iodide; CAS no. 13213-99-5) was synthesized by combining N,N-diethylethanolamine and methyliodine in THF, followed by extensive washing with dry THF. The product was validated by ESI-MS ([M] ϩ ϭ 132.18) and was greater than 95% pure by relative ion abundance (some THF remained). MS/MS fragmentation resulted in two major expected fragments: (i) loss of the ethanol group from the amine ( [M] ϩ ϭ 88.16), and (ii) loss of one ethane group from the amine ( [M] ϩ ϭ 104.06). plcH-lacZ reporter assay. ␤-Galactosidase activity driven by the plcHlacZ reporter, pMW22, was measured as previously described (3, 4) .
Briefly, cells grown overnight in MOPS minimal medium (16) amended with 20 mM sodium pyruvate and 5 mM D-glucose were collected by centrifugation and resuspended in MOPS with 20 mM pyruvate and 250 M the appropriate small molecule. Cells were shaken for 4 h under induction conditions at 37°C. The ␤-galactosidase assays were conducted according to Miller (18) .
Growth conditions and RNA preparation for microarrays. For the choline and choline analogue-induced arrays, P. aeruginosa PA14 and PA14-derived strains (Table 1) were grown overnight in MOPS minimal medium (16, 17) with 25 mM pyruvate and 5 mM glucose on a rotating wheel at 37°C. Cells from this overnight growth were harvested by centrifugation, washed with 1ϫ MOPS minimal medium at room temperature, and resuspended in 1ϫ MOPS at an optical density at 600 nm (OD 600 ) of 0.6. To begin induction, 0.75 ml of this cell suspension was added to 0.75 ml of prewarmed 2ϫ induction medium (1ϫ MOPS medium, 20 mM pyruvate, 500 M choline/choline analogue) to give a final cell OD 600 of 0.3 and the final target concentrations of choline or choline analogue. The final induction medium contained 1ϫ MOPS, 20 mM pyruvate, and 250 M choline or choline analogue. Cells were induced during growth in 12-well plates mixed on a horizontal shaker at 37°C for 4 h prior to RNA isolation. The final OD 600 was between 0.4 and 0.45 for all samples.
Cells from the induction cultures were harvested by centrifugation, resuspended in a mixture of 0.5 ml 10 mM Tris-HCl and 0.1 mM EDTA (pH 8.0) (TE buffer), and mixed with 1 ml RNAprotect bacterial reagent (Qiagen) as per the manufacturer's instruction. The resultant pellet was resuspended in TE buffer with 3 mg/ml lysozyme, processed, and column purified using RNeasy columns (Qiagen) according to the manufacturer's instructions, including on-column RNase-free DNase I treatment. Eluted samples were treated a second time with RNase-free DNase I (New England BioLabs), applied to fresh RNeasy columns, and purified according to the manufacturer's directions.
Microarray methodology. Microarray analyses were performed on a Pseudomonas aeruginosa PAO1 gene chip using oligonucleotide probes generated from each condition using the NuGen Pico system. Each condition was analyzed in duplicate (n ϭ 2) and summarized in one probe intensity by the Vermont Genetics Network Microarray Facility using Affymetrix GCOS software. Information from multiple probes was combined to obtain a single measure of expression for each probe set and sample. Probe-level intensities were background-corrected, normalized, and summarized, and robust multichip average (RMA) statistics were calculated for each probe set and sample as is implemented in Partek This pathway is based on data from us and others (2, 27) and regulation data presented in this article.
Genomic Suites, version 6.6 (Partek, Inc., St. Louis, MO). Sample quality was assessed based on relative log expression (RLE) and normalized unscaled standard error (NUSE). To identify differentially expressed genes, linear modeling of sample groups was performed using analysis of variance (ANOVA) as implemented in Partek Genomic Suites. The magnitude of the response (fold change calculated using the least-squares mean) and the P value associated with each probe set and binary comparison were calculated. qRT-PCR to measure induction dependence on GbdR. To test whether GbdR was necessary for the transcriptional changes of previously unverified transcripts, we grew cells as described for the microarray preparation, except that wild-type (WT) and ⌬gbdR mutant cells were exposed to pyruvate or 1 mM choline in MOPS pyruvate medium for 3 h. RNA was prepared as described for the microarray experiments. cDNA was generated using Superscript III (Invitrogen) and the 5=-NSNSNSNSNS-3= primer as described previously (19) . Quantitative PCR (qPCR) was performed using the Luminaris color HiGreen fluorescein qPCR master mix (Thermo Scientific) with the primers described in Table S1 in the supplemental material. Abundance was normalized to a five-step standard curve dilution series of the most induced sample (WT with choline) for all transcripts except lipA, and a dilution series of the WT pyruvate noninduced sample for quantification of lipA. Each sample for each transcript was normalized to its cognate rplU abundance before conversion to relative expression based on the average expression level of the WT pyruvate sample. Data were analyzed using GraphPad Prism using one-way ANOVA with a Dunnett's corrected posttest, where comparisons were made to each transcript's WT pyruvate level.
MBP-GbdR fusion protein: cloning and protein preparation. The GbdR coding sequence (gbdR, PA5380) was amplified from PAO1 genomic DNA using the primers pMAL-c2X-GbdR-F-EcoRI and pMALc2X-GbdR-R-HindIII (for sequences, see Table S1 in the supplemental material), and the product was cloned into pMAL-c2X (NEB) using the EcoRI and HindIII restriction sites, creating an N-terminal maltose binding protein (MBP) fusion construct that eliminated the ATG start codon from the original gbdR sequence. This plasmid is designated pKH10.
To express the MBP-GbdR fusion protein, pKH10 was transformed into New England BioLabs T7 Express lysY/I q competent E. coli. A 400-ml culture (LB plus 100 g/ml carbenecillin) of the pKH10-transformed E. coli was grown to an OD 600 of 0.5, and fusion protein production was induced for 4 h with 1 mM IPTG (isopropyl-␤-D-thiogalactopyranoside) at 37°C. The cell pellet was harvested by centrifugation and then washed twice with ice-cold buffer 1 (20 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA [pH 8.0]). The final pellet was resuspended in buffer 1 and then amended to 1ϫ Halt protease inhibitor cocktail (Thermo-Fisher) and 3 mg/ml lysozyme. The resultant lysate was passed two times through a 25-gauge needle and then clarified by centrifugation for 1 h at 20,000 ϫ g. The lysate was then applied to a column of amylose resin (New England BioLabs), washed with column buffer (20 mM Tris HCl, 150 mM NaCl, 1 mM EDTA [pH 7.4]), and eluted with 10 mM maltose in column buffer according to the manufacturer's instructions. Column fractions containing electrophoretically pure fusion protein were pooled and dialyzed extensively against buffer 1 at 4°C in 10-kDa molecular-mass-cutoff Slide-A-Lyzer cassettes (Thermo-Fisher). Aliquots of protein were flash frozen in liquid nitrogen and stored at Ϫ80°C.
EMSAs to assess GbdR binding to DNA. Electrophoretic mobility shift assays (EMSAs) were conducted as described previously (3). Briefly, DNA fragments for EMSA analysis were made by PCR amplification, verification of a single band by SYBR Safe staining, and spot dialysis. For labeled DNA, one of the primers contained a covalently linked 5=-biotin tag (IDT). EMSAs were conducted as per the manufacturer's instructions (Pierce LightShift) with changes made as described previously (3) . Binding reactions were electrophoresed on nondenaturing 5% TBE gels, transferred to BioDyne-B nylon membrane (Pierce), and detected using the supplied streptavidin-horseradish peroxidase (HRP) protocol (Pierce). EMSA probe primers are described in Table S1 , and plcH probe primers were described in reference 3.
DNase I footprinting. Target DNAs for footprinting experiments were generated by PCR amplification of the P. aeruginosa plcH promoter region using the primers plcH_PB_For2_XbaI and plcH_PB_Rev1_ BamHI (described in reference 3). Individual strand end labeling with 32 P was accomplished by 5=-end phosphorylation of one of the two primers using T4 polynucleotide kinase and [␥-
32 P]ATP. Labeled and unlabeled primers were used in equimolar proportions during PCR, and the radiolabeled PCR products were purified from 5% polyacrylamide Tris-borate-EDTA (TBE) gels.
DNase footprinting experiments were conducted essentially as described by Brenowitz and coworkers (20) . MBP-GbdR was diluted in buffer 1 (see protein purification method) prior to addition to the binding reaction such that buffer 1 components were present at 1/10 their original concentration or less. After precipitation and denaturation, reaction products were separated on 6% polyacrylamide gels (19:1 acrylamidebisacrylamide) and exposed to X-ray film.
PA4921 (choE)-lacZYA translational reporters and GbdR binding. The promoter region and 5= untranscribed region (UTR) of PA4921 (choE) were amplified from PA14 genomic DNA using the primers PA4921_transllacZYA_For and PA4921_transllacZYA_Rev (see Table S1 in the supplemental material) to generate a translational reporter fusion to LacZ (pMW199). A target lacZYA-containing vector suitable for yeast (Saccharomyces cerevisiae) cloning (pMW42) was generated by excising the lacZYA region from pMW5 (3) with HindIII and EcoRI and cloning into the similarly cut pMQ80 backbone (21) , which removes egfp-mut3. The pMW42 vector was digested with KpnI and mixed with the PA4921 promoter PCR product followed by yeast transformation and selection according to the methods of Shanks et al. (21) . Plasmid was prepared from yeast and transformed into E. coli as previously described (3). Transcriptional induction and ␤-galactosidase activity were determined as described above for the choline analogues and plcH reporter.
Mutations to the predicted GbdR binding site in the PA4921 promoter were generated by PCR using the primers listed in Table S1 in the supplemental material to generate pMW200. The resultant PCR products were cloned by yeast recombination into the pMW42 vector using the method of Shanks et al. (21) . For electrophoretic mobility shift assay (EMSA) experiments, the primers in Table S1 were used for amplification from the pMW199 and pMW200 plasmids to generate the WT and mutant PA4921 promoter probes, respectively. EMSAs were conducted as described above.
Microarray data accession number. Microarray data are available in the GEO Database under accession no. GSE49759.
RESULTS
Ethylcholine induces GbdR-controlled transcripts but cannot be used as the sole carbon source. Genetic deletions have existed for many generations prior to the assay in which they are analyzed, and it is recognized that bacteria can phenotypically respond to and sometimes attempt to compensate for deletions in many metabolic pathways. In our case, choline is present in LB and PIA media, and the catabolic genes are strongly induced during the stationary phase (22) . Chemical probes have a long history of utility in avoiding such drawbacks of permanent genetic changes to solve transcriptional regulatory networks (23) . To implement a chemical biology strategy to compare with our classical genetics approach, we were interested in generating choline analogues that were converted by the cell into GbdR inducers that were noncatabolizable-analogous to IPTG for this induction system. We generated and screened a number of choline analogues, some previously described (4), in order to identify a choline analogue that was converted to a strong inducer of GbdR-dependent transcription. We identified ethylcholine ( Fig. 2A) as a compound that could not be used as the sole carbon source and did not act as an inhibitor to the choline catabolic pathway (Fig. 2B ) but led to robust induction from a GbdR-controlled promoter (Fig. 2C) . Ethylcholine did not induce GbdR-dependent transcripts in a betBA mutant (Fig. 2C) , suggesting that it requires oxidation by BetBA to become an inducing analogue, as does choline (2, 10). We also looked for structurally similar analogues that did not induce GbdR-dependent transcripts and identified diethylcholine ( Fig. 2A) as a nonmetabolizable (Fig. 2B) and noninhibitory (Fig.  2B ) choline analogue that does not induce GbdR-dependent transcription (Fig. 2C) .
We predict that both of these choline analogues are imported into the cell and modified by the choline oxidase to generate a betaine or dimethylglycine version of the analogue. Our evidence for import is that both can alter transcription of the BetI-regulated genes (betIBA and betT1) in the absence of choline (see Table S2 in the supplemental material). A second piece of evidence for intracellular oxidation to at least a GB analogue is that both compounds can provide weak but measureable osmoprotection (data not shown), a critical property, as choline itself does not act as an osmoprotectant in P. aeruginosa (10) . After characterization of these two analogues, we employed them as two components in our microarray scheme to identify transcripts in the GbdR regulon.
Combined genetics and chemical biology approaches to define the GbdR regulon. Our goal was to define the core GbdR regulon by employing multiple conditions that elicit GbdR-dependent transcript induction. Multiple induction conditions reduce the possibility of incorporating false positives into the GbdR regulon. We did not use comparison to a gbdR mutant, as GbdR regulates import of choline, GB, and dimethylglycine (24) , which could have additional indirect effects on the cells under these conditions. We avoided using high concentrations of choline or GB in order to eliminate potential secondary metabolic effects (25, 26) and also to reduce changes due to downstream metabolites and potential changes to C1 and C2 carrier pools (27) . Therefore, we chose to compare induction in the presence of 250 M choline or choline analogues. In the wild type (WT), this level of inducer shows a barely detectable induction of target genes by qRT-PCR (data not shown), and this induction does not generate a statistically significant signal in our microarray experiments for known GbdR targets and only statistically changed a single transcript (see Table S2 in the supplemental material). This allowed us to conclude that the 250 M concentration of choline has little transcriptional effect on the cell under these conditions at this time point. We compared WT cells grown in pyruvate plus choline and WT cells grown in pyruvate alone to samples from the four other conditions detailed below.
We previously demonstrated that genetic deletion or chemical inhibition of the dimethylglycine demethylase (dgcA) resulted in accumulation of dimethylglycine and resultant hyperinduction of known GbdR-controlled transcripts (4). Therefore, we used choline addition to a dgcA deletion mutant and propargylcholine inhibition of DgcA in the presence of choline (4) as two of our microarray conditions. The other two conditions were ethylcholine as a nonmetabolizable GbdR inducer and diethylcholine as a noninducing control compound. A schematic of the rationale behind this transcriptomics experiment is presented in Fig. 3 . Comparison of these four conditions to the WT with pyruvate or choline allowed us to identify a set of coregulated genes ( Table 2) that were strong candidates for GbdR regulon members.
We defined a GbdR regulon member as a transcript that (i) was called present in at least one condition on the array, (ii) whose change in abundance was statistically significant, and (iii) that showed more than a 2.5-fold difference compared to the WT grown in pyruvate under all three inducing conditions (ethylcholine, choline plus propargylcholine, and ⌬dgcA plus choline), but (iv) was unchanged in the diethylcholine-treated and cholinetreated WT cells. In summary, there are 25 genes whose transcript abundance is Ͼ2.5-fold higher than that of the WT pyruvate control under all three GbdR-hyperinducing conditions but not in WT plus choline or WT plus diethylcholine (Table 2 ). These genes are predicted to be encoded on 11 transcripts whose production is driven from at least 9 predicted GbdR binding sites. The plcH and pchP loci had been previously demonstrated as being under direct GbdR control (3), while genetic evidence had demonstrated a requirement for GbdR to enable GB-dependent induction of the gbcAB, dgc, soxBDAG (2) , and cbcXWV (24) transcripts. We used When ethylcholine (EtCho) and diethylcholine (DiCho) were added in addition to choline (right two bars), they were present at 10 mM. (B) Results from the ␤-galactosidase assay with a plcH-lacZ reporter plasmid in the WT or the ⌬betBA mutant strain (bet). Cultures were grown in MOPS with 20 mM pyruvate (Pyr), and 1 mM each of the compounds labeled on the x axis was added. Fold induction was calculated as a multiple of the pyruvate condition for each strain. Statistical significance was determined using one-way ANOVA with Dunnett's posttest for panels B and C with choline alone or the uninduced (Pyr) condition being the comparator for all other data, respectively. n.s., not significant; ****, P Ͻ 0.0001. The data shown are the summary of three independent experiments, each with three biological replicates; therefore, error bars represent standard errors of the means.
qRT-PCR to demonstrate that choline-induced transcription from the previously unstudied loci was also gbdR dependent (Table 3) .
We also noted that the lipA transcript (PA2862) was the only transcript whose abundance decreased under these conditions in a manner befitting a member of the GbdR regulon (Tables 2 and 3) . LipA is a secreted lipase (triacylglycerol acylhydrolase) that is typically abundantly expressed in lipid environments (28) . As described below, there is no evidence that lipA is a direct GbdR target, and we currently have no evidence that GbdR can act as a ligand-dependent repressor, so the mechanism of lipA regulation is unknown.
Verification of the potential regulon members via EMSA. Based on our microarray data and genetic evidence for GbdR dependence (Tables 2 and 3) , we assayed the ability of purified GbdR to bind each promoter. We also used competition by unlabeled DNA containing the known GbdR binding site from the plcH promoter to test relative affinities. As demonstrated in Fig. 4 , all of the induced promoters were capable of binding to purified MBPGbdR, although binding to the PA2761 and PA2762 promoters was relatively weak. The promoter of lipA did not show any binding to GbdR. The dhcA promoter was a negative control known not to be responsive to GB or DMG (29) . The in vitro binding suggested direct GbdR control at these promoters and that these promoters could be used for bioinformatic comparisons to derive a GbdR consensus sequence.
Determination of the GbdR footprint. To constrain the boundaries of the GbdR consensus sequence and map the contact region of GbdR, we used DNase I footprinting with purified MBPGbdR in association with the plcH promoter. Using this strategy, we show that GbdR binds to a 33-bp stretch of the plcH promoter (Fig. 5A ) that maps roughly to the GbdR binding site previously suggested by sequence alignment, promoter mapping, and mutation (3). This whole footprint can be broken down into two 10-to 11-bp direct repeat half-sites with a 9-to 10-bp spacer, a very similar arrangement to the related ArgR transcription factor in P. aeruginosa (Fig. 5B) (30) .
Generation of GbdR consensus site and search of the P. aeruginosa genome. To define the overall consensus for GbdR binding to the promoters of regulon members, we aligned the promoters of all of the members of the GbdR regulon and used the plcH-GbdR DNase I footprint to constrain the search region (Fig.  5A) . With these constraints, we used MEME to generate a sequence logo corresponding to the consensus sequence (Fig. 5B) . We used this resultant GbdR binding site consensus, GDCGYnnnMRB-(9 to 11 n's)-GDCGYnnnMR, to search the PAO1 genome for potential GbdR binding sites that we may have missed due to low induction levels, different induction kinetics, or poor probe set discrimination. The consensus is represented using the IUPAC degenerate symbols defined as follows: D, not C; Y, pyrimidine (T, C); M, amino (A, C); R, purine (A, G); and B, not A. The proposed consensus, including both invariant and varyingly degenerate bases, is very GC rich-common in the P. aeruginosa genome. Therefore, we filtered our search results to only those sites located within intergenic regions and found 23 sites (see Table S3 in the supplemental material). Six predicted sites were in the promoters of the genes identified in the microarray, and three sites strains were subjected to six experimental conditions with two arrays per condition from separate biological samples. The treatment level denotes the compound added to basal MOPS pyruvate medium-all at 250 M, except propargylcholine (propcho), which was added at 500 M as a DgcA inhibitor. The "metabolic consequence" level details the predicted accumulation of relevant metabolites. The glycine betaine forms of diethylcholine and ethylcholine are abbreviated diGB and ethylGB, respectively. The predicted effects on GbdR are based on our previous studies and the data in Fig. 2 . were found adjacent to transcripts that were reduced compared to those in the WT under one or two of the GbdR-inducing microarray conditions but not under all three (see Tables S2 and S3 in the supplemental material). We did not find the glyA1 and PA2761 binding sites in the intragenic list, as the GbdR binding sites regulating these genes are present within the coding sequences of adjacent genes. No consensus binding site was found for PA2762, although there are three consensus half-sites located within the promoter, two pairs of which are spaced 7 bp and 14 bp apart, respectively, a topic revisited in the Discussion section. We also identified a consensus "GbdR site" in the divergent regulatory region between caiX and cdhR, which is carnitine responsive in a CdhR-dependent manner (29) . We presume that the high sequence similarity between GbdR and CdhR (44% identical, 63% similar) possibly led to identification of the CdhR binding site location. Based on previous research demonstrating choline metabolite-dependent induction in P. aeruginosa (15), we followed up on the binding site upstream of the choE gene (PA4921), encoding the acetylcholine esterase. Identification of choE (PA4921) as a GbdR-controlled transcript. One of the potential GbdR-binding sites (see Table S3 in the supplemental material) was upstream of the PA4921 gene, recently described as an acetylcholine esterase and renamed choE (15) . P. aeruginosa acetylcholine esterase activity had previously been shown to be induced by GB and dimethylglycine, but not sarcosine, in a manner similar to other GbdR-dependent transcripts (31, 32 ). Here we demonstrate that choE-lacZ reporter activity is regulated in a gbdR-dependent manner and that purified Bands that are likely PCR artifacts and do not shift in the analysis are marked with the letter "n." The mutant plcH probe (plcH**) was previously described (3). All blots are representative of at least three independent experiments.
FIG 5 DNase I footprint analysis and consensus generation. (A) End-labeled
plcH promoter was subjected to limited DNase I digestion to determine the region protected by MBP-GbdR. The left shows the entire blot, and the right image is a magnified view of the area denoted by the black lines. As the MBPGbdR concentration increased, an ϳ32-bp region was protected from DNase I digestion. The first lane is the A-and-G sequencing ladder for this fragment.
(B) The consensus GbdR binding site logo generated by MEME (39) for all induced members of the GbdR regulon with the exception of PA2762 (see Discussion). The asterisks below the sequence logo denote the 2 bp of the consensus sequence mutated in the choE promoter (Fig. 6 ).
GbdR can bind to the choE promoter in vitro ( Fig. 6A and B) . Using mutagenesis of two consensus base pairs shown to be important for GbdR binding to the plcH promoter (CG to AA in half-site 1 [marked with stars in Fig. 5B] ) (3), we demonstrate that these 2 bp, absolutely conserved in the GbdR consensus (Fig. 5B) , are required for gbdR-dependent induction (Fig. 6A ) and for GbdR binding to the choE upstream region (Fig. 6B) .
DISCUSSION
To dissect the response of an organism to changing environmental conditions, it is critical to understand the role of the regulatory proteins governing physiology and metabolism under those conditions. Transcription factors play an important role in the P. aeruginosa response to changing conditions, but we do not know the core regulons of more than a few transcription regulators in this organism. Here we characterized the core regulon of the catabolism and virulence regulatory transcription factor GbdR and used DNA binding and DNase I protection to describe the binding sites. Our analyses confirmed the inclusion of the gbcA and -B genes, dgc operon (PA5396 to PA5402), and soxBDAG operon in the GbdR regulon and as direct GbdR targets, a prediction that was previously based on lack of induction in a gbdR deletion mutant (2) . Based on our findings, the GbdR regulon also includes the glyA1, purU2, and fdhA genes associated with the soxBDAG operon, as well as the serine deaminase encoded by sdaB (Fig. 1 ). These four genes were known or predicted to be involved in choline and GB catabolism (2, 27) . This study solidifies the central position of GbdR in the control of the GB catabolic pathway, as it directly regulates transcription of the genes involved in all steps of conversion from GB to pyruvate (Fig. 1) . However, based on previous data, the later steps of this pathway encoded by glyA1-soxB-DAG-purU2fdhA are also under regulation of an alternate unidentified transcription factor that is responsive to sarcosine (2) . The GB periplasmic binding protein, BetX, and the choline/betaine/ carnitine ABC transporter, CbcXWV (as predicted by genetic experiments [24] ), are also regulated by direct binding of GbdR, broadening the scope of GbdR control from acquisition (plcH and pchP), to transport, and, finally, to full catabolism of GB to pyruvate. Interestingly, the two-step conversion of choline to GB remains outside GbdR's purview, controlled instead by the TetR family regulator BetI (13, 14) (Fig. 1) . We suggest that this separation of regulation within the pathway has implications for control of cytosolic levels of choline and GB and the resulting virulence and stress responses (33) . The harvest, transport, and catabolic genes in the GbdR regulon are conserved in a variety of bacteria that aerobically metabolize choline (partially demonstrated in reference 4), and some of these genes have been shown to be controlled by the GbdR ortholog in Pseudomonas syringae (34) . However, there are two genes that have a much more restricted distribution: PA2761 and PA2762. PA2761 encodes a predicted transmembrane protein with no additional functional information that is located downstream of oprQ, which encodes an OprD family porin involved in virulence (35) . PA2762 encodes a small protein that is part of the cupin-3 superfamily (DUF861). While PA2762 has orthologs in all sequenced pseudomonads, except P. syringae, PA2761 orthologs are only present in the genomes of P. aeruginosa strains and are always associated with oprQ orthologs. However, there are oprQ orthologs in all of the pseudomonads, ruling out PA2761 as being required for OprQ function in a taxonomically broad sense. Neither PA2761 nor PA2762 is required for growth on choline, GB, or DMG, or for PlcH production as measured by analyses of transposon mutants of each gene from the PA14 transposon library (data not shown). Therefore, while we can ascribe a function to nearly every gene in the core GbdR regulon, the functions of PA2761 and PA2762 remain a mystery.
We were also able to expand the GbdR regulon beyond the microarray-defined core set of genes to include choE (PA4921), which has been shown to encode a protein with acetylcholine esterase activity (15) . Based on its enzymatic activity, we can group ChoE with PlcH and PchP as part of the choline acquisition system regulated by GbdR. Thus, GbdR is the key regulator of choline acquisition from the major choline-containing molecules produced by eukaryotes: phosphatidylcholine (via PlcH), sphingomyelin (via PlcH), phosphorylcholine (via PchP), and acetycholine (via ChoE). These choline acquisition activities are a key step in the positive-feedback induction loop governed by GbdR. GB acquired through oxidation of host-derived choline results in more transcriptional activation of GbdR-regulated targets, which include the acquisition machinery. There are two caveats to this simple view. First, choline oxidation is expressly not under GbdR control but rather controlled by BetI, as described above. Second, by simultaneously inducing catabolism of the activating mole- assay with a choE-lacZ reporter plasmid in the wild type (WT) or the ⌬gbdR mutant strain (⌬) or the choE mutant promoter lacZ reporter in the WT strain (P*). Cultures were grown in MOPS with 20 mM pyruvate (Pyr) with 1 mM concentrations of each of the compounds labeled on the x axis. Fold induction was calculated as a multiple of the pyruvate condition for each strain. Statistical significance was determined using one-way ANOVA with Dunnett's posttest, with the uninduced (Pyr) condition being the comparator for all other data. Sarc, sarcosine. n.s., not significant; ***, P Ͻ 0.001. (B) Electrophoretic mobility shift assay with purified MBP-GbdR using the wild-type choE promoter (PchoE) or the 2-bp mutant choE promoter (PchoE-mut). The amount of MBP-GbdR added to each binding reaction mixture is noted below each lane. This blot is representative of more than three independent experiments. cules (GB and DMG), GbdR also promotes its own inactivation. Analogous to BetI control of the choline oxidation genes, we predict that the dual competing activities of GbdR on the cytosolic pool of GB are regulated to maintain GB homeostasis (33, 36) .
Jackson et al. recently analyzed the changes in transcript levels of P. aeruginosa exposed to pulmonary surfactant and compared the WT to both plcH and gbdR mutants (37) . The bulk of pulmonary surfactant is phosphatidylcholine, and it also contains sphingomyelin; therefore, lung surfactant is a rich source of cholinecontaining molecules. We compared our analyses to their microarray data from the GEO database (GSE41926). All of our core regulon members (Table 2) are also reduced in ⌬gbdR cells grown in surfactant compared to WT, supporting both the acquisition of choline from lung surfactant and the role of GbdR in regulating these genes under physiologically relevant conditions. While lung surfactant is predominately phosphatidylcholine, there are a number of other compounds present that make direct causation difficult but provide useful information regarding the impact of GbdR on other genes. Of particular note is the reduction in transcript levels for Anr-controlled genes in both the gbdR and plcH mutants grown in surfactant, which does not occur in our arrays. Jackson et al. provide clear evidence that choline metabolites regulate Anr, but the direct mechanism of this regulation is not currently known (37) .
In addition to the GbdR core regulon and the Anr-controlled genes, the surfactant arrays of Jackson et al. also demonstrate a number of other transcripts that changed in both plcH and gbdR deletions compared to WT (37) . We used our consensus GbdR binding site search results (see Table S3 in the supplemental material) to examine their array data to see if genes changed in the gbdR mutant transcriptome in surfactant were linked to consensus GbdR-binding sites. We found that four transcripts with upstream intragenic consensus GbdR-binding sites were altered in the gbdR mutant compared to the WT; all had reduced transcript levels in the gbdR mutant (see Table S3 ). One of these transcripts was choE (PA4921), which we have experimentally verified here. The other transcripts reduced in ⌬gbdR in the lung surfactant arrays with nearby GbdR-consensus binding sites were fhpR, PA3467, and PA4387. In addition to these surfactant array changes, three transcripts were also changed in a subset of our GbdR-activating arrays but did not meet the strict requirements of regulon inclusion: coaD, sucA, and PA2666 (see Table S3 ). These alternate genes may represent GbdR targets under conditions that were not met in our experiments or may be due to indirect effects of GbdR activity. The choline concentration in our initial microarrays was chosen to attempt to isolate the core regulon, not identify all possible transcripts influenced by GB or DMG accumulation.
An informed examination of the GbdR binding site consensus and the large number of potential binding sites in the genome (598 total consensus matches, 23 of which were intragenic [see Table S3 in the supplemental material]) strongly suggests that not all relevant information to enable GbdR-dependent regulation is contained by the consensus summary. Thus, to fully understand GbdR-dependent regulation, we need to conduct further examinations. First, there is likely additional cryptic information within the binding site boundaries that determines whether GbdR binds and how well it binds. Our current analyses look at each residue as independently variable or conserved, but more likely groups of residues can cooperatively alter GbdR binding, and/or change in one residue can compensate for changes in other residues. The second possibility is that there are additional sequence elements outside the binding site borders that impact GbdR binding. Finally, there could be other factors, including location in the genome or the nucleoid and association with other proteins that can ultimately fine-tune GbdR-dependent transcriptional induction.
Apart from further study of the binding site itself, GbdR is one of the few AraC regulators in the type 1 glutamine amidotransferase (GATase1)-like domain family (cd03136) that has been studied. This general domain belongs to the ThiJ/DJ-1/Pfp1 superfamily of proteins. One difference in these AraC family GATase1 members is that they do not possess the catalytic triad of the amidotransferase but often retain a highly conserved cysteine residue that functions in the DJ-1 members as a sensor for radiation stress (38) . For this subfamily, we do not know how flexible the dimerization interface is, how ligand binding alters structure, or if there is possibility for heterodimerization with other GATase1-containing AraC family members, of which there are at least six additional members in the genome (ArgR, PA1850, PA3782, PA4184, PA4436, and CdhR). Our lack of understanding might explain GbdR-dependent regulation even in the presence of the abnormal binding site arrangement in the PA2762 regulatory region, where spacings of either 7 or 14 bp fall outside the canonical span between half-sites, at least compared to the other GbdRsites described in this study. This subfamily of AraC regulators is present in nearly all sequenced bacteria, and GbdR may provide a useful model system to expand our understanding across these evolutionarily related proteins.
